NDC 0591-0343

Verapamil Hydrochloride

Verapamil Hydrochloride

Verapamil Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Verapamil Hydrochloride.

Product ID0591-0343_6fa625d9-b02d-4905-8e72-eecf0d6aaf8e
NDC0591-0343
Product TypeHuman Prescription Drug
Proprietary NameVerapamil Hydrochloride
Generic NameVerapamil Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1986-10-01
Marketing CategoryANDA / ANDA
Application NumberANDA070995
Labeler NameActavis Pharma, Inc.
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength80 mg/1
Pharm ClassesCalcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0591-0343-01

100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0343-01)
Marketing Start Date1986-10-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-0343-01 [00591034301]

Verapamil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA070995
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1986-10-01

NDC 0591-0343-10 [00591034310]

Verapamil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA070995
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1986-10-01

NDC 0591-0343-05 [00591034305]

Verapamil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA070995
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1986-10-01

Drug Details

Active Ingredients

IngredientStrength
VERAPAMIL HYDROCHLORIDE80 mg/1

OpenFDA Data

SPL SET ID:a0343397-897b-46d6-943f-a87e07e1de10
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897666
  • 897722
  • 897683
  • Pharmacological Class

    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]